NEURONOMIC PLUS, is an extension to the parent brand NEURONOMIC, patented across India, USA, Australia, and 94 other countries. It works by scavenging free radicals, reducing iron overload and improving cognitive function, thereby improving QOL in neurodegenerative disorder patients.
This combination of carefully selected ingredients is designed to address arthritis-related pain and inflammation, making it an ideal choice for orthopaedic use. It supports effective pain management and improves joint health.
PALMIGES PLUS serves as an extension to PALMIGES core brand as a Once Daily pill and is patented in India and 55 other countries across the Globe. The product is intended to be Once Daily dose solution to assist in Chronic pain of different aetiologies by working to reduce neuronal inflammation.
PALMIRESP is a unique anti-inflammatory combination of Palmitoylethanolamide, Boswellia Serrata Extract and Pine Bark Extract, an adjuvant supplement in hyper responsiveness and chronic airway inflammation.
Nacyres Plus is a unique Patent Applied combination of N-acetyl derivative of endogenous amino acid N-acetyl-L-cysteine and glycoprotein-Lactoferrin which shows synergistic mucolytic action.
Ironemic Plus is a promising combination of 100 mg Lactoferrin, 5 mg Disodium Guanosine 5-monophosphate, 19 mg Elemental Iron (Ferrous Bisglycinate) & 60 mg Vitamin C formulated to provide a distinctive solution for Iron deficiency anemia and anemia of Chronic Diseases. Vitamin C gives additional benefit to absorb the elemental iron.
Ironemic is a promising combination of 50 mg Lactoferrin, 5 mg Disodium Guanosine 5-monophosphate and 19 mg Elemental Iron (Ferrous Bisglycinate) formulated to provide a distinctive solution for Iron deficiency anemia and anemia of Chronic Diseases.
FIDOTOX is a product which contains Inulin 10 g and Betaine 0.3 g that has been scientifically proven to reduce Indoxyl Sulfate and p-Cresyl sulfate – the two PBUTs in CKD and HD patients. It works on the concept of generating SCFA (Short Chain Fatty Acid), increasing Saccharolytic bacteria and decreasing proteolytic bacteria. FIDOTOX is patented in several countries including Europe (BE, FR, DE, IE, LI, LU, MC, CH & GB).
HEPAGRESS is a unique approach towards the treatment of Helicobacter pylori infection. It provides a satisfactory H. pylori eradication rate along with standard triple therapy of esomeprazole, clarithromycin, and Tinidazole. It further inhibits the growth and motility of H. pylori and also reduces the incidence of the most common side effects related to anti-Helicobacter pylori therapy.
A NOVEL APPROACH towards managing NAFLD/ NASH patients, QRAHEP modulates and utilizes fat deposited/accumulated on the liver by various approaches like fatty acid transport leading to β-oxidation, promoting β-oxidation of fat inhibiting the synthesis of lipid (fat). It also regulates many co-factors involved in condition like inducing satiety- leading to fed state scenario- so there is no excessive dietary fat, attenuating the liver inflammatory cytokines- making the condition less severe and inhibition of cholesterol synthesis which is the main complication in these conditions.
